Future Labs

In this episode, we are exploring The Future of Voice Biomarkers (and maybe coining the term "voice-omics"!) and the potential to diagnose medical conditions based on voice. We are speaking to Ed Kliphuis, Investment Director at M Ventures, the corporate venture capital arm of Merck KGaA. Ed spoke with us about their recent investment into Sonde Health, a digital medicine company developing diagnostic tools based on voice biomarkers.

Music: Beauty From Nothing by David Ibbett, performed by Sophia Subbayya Vastek

It’s hard to escape a week without seeing the words “artificial intelligence” plastered everywhere. Is it a revolution or just hype? In this episode we are exploring  The Future of AI in Drug Discovery and how artificial intelligence is generating new ideas for new medicines. We’re talking to Jackie Hunter, a Board Director at benevolentAI. Jackie directs the application of BenevolentAI’s technology for clinical development and gives the company the insight it needs to operate its unique business model – one which sees it not only researching, but also developing the blueprint for new drugs.

Music: Beauty From Nothing by David Ibbett, performed by Sophia Subbayya Vastek

Antimicrobial resistance is a growing concern around the globe - the world health organization considers it one of the biggest threats to global health that can affect anyone, of any age, in any country.  In this episode, we are exploring The Future of Antibiotics on why antimicrobial resistance is such a big problem and how to tackle it on multiple fronts. We are speaking to Aleks Engel, Director of the REPAIR Impact Fund, a 165 million dollar initiative dedicated to investing in new anti-infective companies.

Music: Beauty From Nothing by David Ibbett, performed by Sophia Subbayya Vastek

In this episode, we are exploring The Future of Personalized Cancer Treatment and how computer-based modelling can help identify the best ways to tackle cancer in individual patients or patient populations. We are speaking to Kristof Szalay, Founder and CTO of Turbine.ai, a company using computer-based modelling to reveal the potential of new and existing drugs and to help match these to the right patients.

📖 Read the article here!

Music: Beauty From Nothing by David Ibbett, performed by Sophia Subbayya Vastek

In this episode, we are exploring The Future of Digital Therapeutics and how we are moving towards a world where patients can be prescribed a digital product (such as a video game) instead of a drug. We are speaking to Eddie Martucci, Founder and CEO of Akili Interactive, a company developing digital neurological treatments in the form of video games, engineered to directly improve cognitive deficits.

📖 Read the article here!

Music: Beauty From Nothing by David Ibbett, performed by Sophia Subbayya Vastek

In this episode, we are exploring The Future of Open Innovation and how organizations are increasingly sourcing innovation beyond their borders. We are speaking to Sara Holoubek, Founder and CEO of Luminary Labs, a strategy and innovation consultancy firm with expertise in helping clients with Open Innovation. Listen to discover how open innovation is changing your industry.

Music: Beauty From Nothing by David Ibbett, performed by Sophia Subbayya Vastek

Head to www.thefuturelabs.com for more information!

In this episode our host João Ribas explores The Future of Cultured Meat, and how its production may be moving away from the farm and into the lab. We are speaking to Mark Post, CSO of Mosa Meat, a pioneer of this field who is famous for creating the first “Lab-grown burger” in 2013.

We discuss the reasons for developing lab-grown meat, what lab-grown meat actually means and how the public has reacted to the early versions being developed.

Music: Beauty From Nothing by David Ibbett, performed by Sophia Subbayya Vastek

Head to www.thefuturelabs.com for more information!